Supplement 

Action on AMD – Optimising Patient Management: Act Now to Ensure Current and Continual Delivery of Best Possible Patient Care

This document has been produced following an Action on AMD expert on capacity working group consensus meeting held in London in May 2010. Support for initial meeting expenses and logistics was provided by Novartis. Novartis has had the opportunity to review this document for technical accuracy but has had no editorial input. The authors thank Sue Harris from ApotheCom who provided medical writing support on behalf of Novartis Pharmaceuticals.

Acknowledgements

Review